Giant cell arteritis (GCA) is an inflammatory disease that affects medium and large blood vessels, classically the extracranial branches of the external carotid arteries. Inflammation in the wall of the affected artery may cause headache, scalp tenderness, jaw and tongue pain, and visual disturbances, but can also present with systemic or other less common symptoms, so that diagnosis can be challenging. It is a rare disease affecting 2.2 per 10 000 patient-years in the UK.
1
Consequences can be serious if the diagnosis is delayed, and may include visual loss, stroke, and aortic aneurysm. Many patients with GCA first present to their general practitioner or local emergency department. The most common presenting symptom of GCA is headache (76%) 1 but given its relative rarity, other causes of headache are much more common in these settings. Glucocorticosteroids are the mainstay of treatment, but at high doses and for prolonged periods of time are associated with substantial side effects. In April 2019, the National Institute for Health and Care Excellence (NICE) licensed tocilizumab for patients with refractory or relapsing disease.
2 This article provides a practical update for non-specialists with particular emphasis on making a diagnosis and initial management. It also discusses the new NICE guideline on tocilizumab and its likely impact. Who gets it? GCA is relatively rare in a non-specialist setting, with an incidence of 7-29/100 000 population aged >50 in Europe.
3 It is more prevalent in people of northern European ancestry.
3 Frequency increases with age, being very rare in those under 50, with a mean age of onset of 70. 4 As with many other autoimmune diseases, it is more common in women than men (2-6 times more likely).
4
What causes it? Inflammation in the affected blood vessel wall, for example in the carotid artery and its branches, is characterised by the presence of macrophages (which may fuse to form the characteristic giant cells) and CD4+ T lymphocytes.
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This leads to thickening of the intima, and results in reduced blood flow and ischaemia, which is the main cause of pain in the areas that are supplied by the affected vessel (eg, temporal artery involvement can lead to headache). The release of cytokines leads to systemic symptoms.
Why does it matter?
Early diagnosis and treatment of GCA can prevent development of serious complications, such as visual loss. Even when treated, visual loss can occur and be permanent. Before corticosteroid treatment was used to treat GCA, visual loss was noted in 30-60% of patients. 6 If left untreated, up to half of individuals with GCA could sustain unilateral visual loss within days to weeks of symptoms.
7
How do patients present? Symptoms and signs (table 1) frequently occur because of the involvement of arteries arising from the cranial branches of the aortic arch, particularly the extracranial branches of the carotid arteries (fig 1) . 
HOW PATIENTS WERE INVOLVED IN THE CREATION OF THIS ARTICLE
We have discussed living with GCA with several of our patients. Our patients highlighted many important issues, including difficulty obtaining a diagnosis, and were extremely keen that we familiarise more doctors with the condition. They were unanimous about the need to improve diagnosis (such as by using ultrasound) and the side effect burden that is associated with long term glucocorticoid use. We have used this to inform the writing of our article. 
Ask about
Headache-this is the most common symptom, but it isn't always present. When present it is usually a severe temporal headache although GCA can present with occipital or parietal pain. 8 It is quite often insidious in onset but can also be acute. The pain is described as dull in nature but this varies.
Visual symptoms-ask about visual symptoms in anyone presenting with a headache. Is there partial or complete loss of vision or diplopia? Ask specifically about both eyes. If a patient has unilateral eye involvement, the likelihood of the other eye being affected at the same time is 20-50%.
9
Scalp tenderness-is there scalp tenderness when brushing hair?
Constitutional symptoms-fatigue, weight loss, anorexia, and sweats or fevers are frequently present. However, differential diagnoses, such as infection and malignancy, should also be considered.
Pain in the jaw on chewing (jaw claudication)-this is the most common ischaemic complication. Usually pain happens after minutes of chewing over the masseter muscle, due to its ischaemia.
10
Tongue claudication is very rarely the presenting symptom and is present in about 2-4% of patients.
11 Jaw (or tongue) claudication is associated with a high risk of ischaemic complications.
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Proximal muscle pain and stiffnesspatients with coexisting polymyalgia rheumatica (PMR) may report muscle pain, particularly in the proximal arms and legs, and early morning stiffness usually lasting several hours. They often find it difficult to get out of bed in the morning.
Examine
Temporal arteries-palpate the temporal artery to look for tenderness, beading that feels like small hard lumps, and/or decreased or absent pulsation, for example by comparing it with the other side.
Vascular examination-look for large vessel vasculitis features such as bruits (eg, carotid or subclavian artery), decreased arterial pulsation, or a blood pressure differential between arms.
Eyes-check visual acuity and visual fields, looking for anterior ischaemic optic neuropathy secondary to GCA, which may present as monocular loss of vision (over hours to days). Some patients report altitudinal vision loss (either lower or upper half of the visual field is selectively affected) or scotoma. Check pupillary reflexes for a relative afferent defect secondary to optic nerve ischaemia, and perform fundoscopy. Fundoscopy findings are not specific to GCA and may include cotton wool patches, oedema, pale discs, or even haemorrhage.
Scalp-feel for tenderness over the scalp; do not limit your examination only to the skin overlying the temporal artery as arteries supplying the scalp can also be involved.
Perform a thorough general examination, including (but not limited to) cardiovascular, respiratory, and abdominal systems to exclude other differential diagnoses ( At least three of five criteria must be present-sensitivity 93.5%, specificity 91.2%
• Age at onset >50
• New onset headache
• High erythrocyte sedimentation rate (>50 mm/hour by the Westergren method)
• Abnormal temporal artery onpalpation
• Changes consistent with GCA on biopsy Assessing a patient: history and examination
Investigations
Recommended investigations are presented in table 3.
Classification
When classifying patients with vasculitis, the American College of Rheumatology criteria (box) may be helpful, but these are not diagnostic criteria, and should not be used as such. However, the criteria are straightforward to use and may help to start early treatment and trigger specialist referral.
Referral
Refer all patients with suspected GCA urgently to secondary care. If there is visual involvement refer immediately for ophthalmology review. Refer other cases urgently for rheumatology outpatient review to be seen as soon as possible, usually within two weeks. Commence glucocorticosteroids in primary care as soon as the diagnosis is suspected. Many specialist centres have a fast track GCA pathway (fig 2) , which is likely to include prompt review, temporal artery biopsy, with or without ultrasound. Be aware of your local arrangements and discuss atypical cases early with your local specialist. Temporal artery biopsy is currently the gold standard for diagnosis in all patients with suspected GCA. According to the 2010 British Society of Rheumatology guidelines for the management of GCA, a unilateral biopsy of at least 1 cm should be done in an experienced surgical unit. The procedure is usually carried out under local anaesthesia. A positive result means that inflammatory changes are confirmed. According to American College of Rheumatology 1990 criteria for classification of GCA, the specificity of temporal artery biopsy is 73.1% and sensitivity is 92.9%. Do not delay steroid treatment waiting for the results as the diagnosis of GCA is mainly based on clinical judgment, and even with a negative biopsy a patient can still have GCA. Biopsy remains positive for 2-6 weeks after commencing steroids, although the sooner the biopsy is preformed the greater the chance of it being positive. 16 One of the biggest challenges is the high false negative rate due in part to the presence of skip lesions.
Ultrasound is increasingly being introduced as part of the assessment of patients with suspected GCA, to visualise temporal and axillary arteries. Typical findings include a halo suggestive of vessel wall oedema. Monti et al 17 found that ultrasound had a sensitivity of 63% and specificity of 100% in routine clinical practice. Introduction of this technique in their centre led to a decrease in their biopsy rate from 42% to 24%. Other techniques, such as F-18 FDG-PET/ CT, are particularly useful in cases where there are systemic but no localising features. 
